FibroBiologics focuses on the development of regenerative medicine, leveraging stem cell technologies to innovate treatments for various diseases, including liver and kidney disorders.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!